Results 121 to 130 of about 11,185,234 (160)

High affinity monoclonal antibody targeting Siglec-15 for cancer immunotherapy. [PDF]

open access: yesJ Clin Transl Res, 2021
He F   +8 more
europepmc   +1 more source

490 Clinical benefit through Siglec-15 targeting with NC318 antibody in subjects with Siglec-15 positive advanced solid tumors

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Omid Hamid   +14 more
doaj   +1 more source

Siglec-15 regulates cell proliferation, migration and invasion in bladder cancer.

open access: yesAsian Journal of Surgery
Hanyuan Gao, Guang-Jian Liu, Yanru Qiu
semanticscholar   +1 more source

Expression feature and prognostic function of a novel immune checkpoint Siglec-15 in human colorectal cancer. [PDF]

open access: yesHistology and Histopathology
Background. Sialic acid-bound immuno-globulin lectin 15 (Siglec-15) plays an important role in the development of cancer. However, the association between Siglec-15 expression and clinicopathological characteristics of colorectal cancer (CRC) has not ...
Guodong Liang   +7 more
semanticscholar   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

The role of Siglec-15 in tumor immunity: mechanism and therapy.

Molecular Cancer Therapeutics
Siglec-15, a member of the sialic acid-binding immunoglobulin-like lectins (Siglecs) family, has emerged as a pivotal immunosuppressive mediator and a promising therapeutic target in cancer immunotherapy.
Lin Li   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy